Phio Pharmaceuticals Corp. (NASDAQ:PHIO) went up by 0.37% from its latest closing price when compared to the 1-year high value of $24.64 and move down -812.59%, while PHIO stocks collected +1.89% of gains with the last five trading sessions. Press Release reported on 06/08/20 that Phio Pharmaceuticals to Host Key Opinion Leader Call on Intratumoral Therapy with Self-Delivering RNAi on Friday, June 12th
Phio Pharmaceuticals Corp. (NASDAQ:PHIO) Worth an Investment?
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) The 36 Months beta value for PHIO stocks is at 2.22, while of the analysts out of 0 who provided ratings for Phio Pharmaceuticals Corp. stocks as a “buy” while as overweight, rated it as hold and as sell. The average price we get from analysts is $9.00 which is -$2.7 below current price. PHIO currently has a short float of 4.67% and public float of 4.39M with average trading volume of 1.39M shares.
PHIO Market Performance
PHIO stocks went up by 1.89% for the week, with the monthly jump of 3.45% and a quarterly performance of -2.53%, while its annual performance rate touched -87.05%. The simple moving average for the period of the last 20 days is 9.69% for PHIO stocks with the simple moving average of -65.99% for the last 200 days.
PHIO Stocks 26.04% Far from 50 Day Moving Average
After a stumble in the market that brought PHIO to its low price for the period of the last 52 weeks, Phio Pharmaceuticals Corp. was unable to take a rebound, for now settling with -89.04% of loss for the given period.
The stock volatility was left at 15.37%, however, within the period of a single month, the volatility rate increased by 10.23%, while the shares surge at the distance of +9.31% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +22.17% upper at the present time.
In the course of the last 5 trading sessions, PHIO went up by +1.89%, which changed the moving average for the period of 200 days to the total of -85.20% of losses for the stock in comparison to the 20-day moving average settled at $2.47. In addition, Phio Pharmaceuticals Corp. saw -71.29% in overturn over the period of a single year with a tendency to cut further losses.
PHIO Stock Fundamentals
The current profitability levels are settled at -42795.24 for the present operating margin. The net margin for Phio Pharmaceuticals Corp. stands at -42419.05. Total capital return value is set at -90.58, while invested capital returns managed to touch -90.27. Equity return holds the value -104.30%, with -82.10% for asset returns.
Based on Phio Pharmaceuticals Corp. (PHIO), the company’s capital structure generated 9.01 points for debt to equity in total, while total debt to capital is set at the value of 8.27.